Prospective evaluation of the pan-immune-inflammation value (PIV) as an independent prognostic biomarker in EGFR-mutated advanced non-small cell lung cancer.
Year: 2026
Type: conference-abstract
Source: Journal of Clinical Oncology
Institution: Kidwai Memorial Institute of Oncology
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7162690213
Cites:
Cited by:
Related to: